FDA Approval Activities for this Drug
ZOLPIDEM TARTRATE TABLET; ORAL 10MG AMBIEN SANOFI SYNTHELABO ZOLPIDEM TARTRATE TABLET; ORAL 5MG AMBIEN SANOFI SYNTHELABO Zolpidem Tartrate Tablets, 5 & 10 mg, Mylan ANDA 76-578 7/17/03
Zolpidem Tartrate Tablets, 5 & 10 mg, Par Pharmaceutical, ANDA 76-062 ZOLPIDEM TARTRATE Tablet; 10MG AMBIEN LOREX
019908 ZOLPIDEM TARTRATE Tablet; 5MG AMBIEN LOREX | Zolpidem Tartrate orally disintegrating tablets, Biovail Tech, Tentative Approval | Zolpidem Tartrate orally disintegrating tablets, TEVA Pharma, Tentative Approval | Zolpidem Tartrate Tablet, Caraco Pharma, Tentative Approval | Ambien CR (zolpidem tartrate) Extended-Release Tablets, Sanofi-Synthelabo, Approval | Zolpidem Tartrate Tablet, Pliva, Tentative Approval | Zolpidem Tartrate Tablet, Synthon Pharma, Tentative Approval | Zolpidem Tartrate Tablets, Mutual Pharma, Tentative Approval | Zolpidem Tartrate Tablet, Watson Laboratories, Tentative Approval | Zolpidem Tartrate Tablet, Apotex Inc., Tentative Approval | Zolpidem Tartrate Orally Disintegrating Tablets, Biovail Labs, Tentative Approval | Zolpidem Tartrate Tabelt, Cipla Ltd., Tentative Approval | Zolpidem Tartrate Tabelt, Genpharm Inc., Tentative Approval | Zolpidem Tartrate Tablets, Ranbaxy Labs, Tentative Approval